-
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.
Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E.
Am J Obstet Gynecol 2017;216:110-120.e6. pdf -
Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE)
O'Gorman N, Wright D, Rolnik DL, Nicolaides KH, Poon LC.
BMJ Open 2016;6:e011801. pdf -
Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis.
Roberge S, Demers S, Nicolaides KH, Bureau M, Côté S, Bujold E.
Ultrasound Obstet Gynecol 2016;47:548-53. pdf -
Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus.
Syngelaki A, Nicolaides KH, Balani J, Hyer S, Akolekar R, Kotecha R, Pastides A, Shehata H.
N Engl J Med 2016;374:434-43. pdf -
Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation.
Bujold E, Roberge S, Nicolaides KH.
Prenat Diagn 2014;34:642-8. pdf -
Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis.
Roberge S, Nicolaides KH, Demers S, Villa P, Bujold E.
Ultrasound Obstet Gynecol 2013;41:491-9. -
Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis.
Roberge S, Giguère Y, Villa P, Nicolaides KH, Vainio M, Forest JC, von Dadelszen P, Vaiman D, Tapp S, Bujold E.
Am J Perinatol 2012;29:551-6.